Jury rules for drugmaker, dealing blow to U.S. over HIV patent lawsuit
Washington Post
A federal jury in Delaware rejected claims by the U.S. government that Gilead Sciences infringed on its patents as it made billions of dollars selling Truvada for PrEP.
https://www.washingtonpost.com/business/2023/05/09/gilead-truvada-prep-hiv-patent-case/